These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 36370551)
1. Discovery of 1-hydroxy-2-methylquinolin-4(1H)-one derivatives as new cytochrome bd oxidase inhibitors for tuberculosis therapy. Zhou Y; Shao M; Wang W; Cheung CY; Wu Y; Yu H; Hu X; Cook GM; Gong H; Lu X Eur J Med Chem; 2023 Jan; 245(Pt 1):114896. PubMed ID: 36370551 [TBL] [Abstract][Full Text] [Related]
8. Structure guided generation of thieno[3,2- Hopfner SM; Lee BS; Kalia NP; Miller MJ; Pethe K; Moraski GC RSC Med Chem; 2021 Jan; 12(1):73-77. PubMed ID: 34046599 [TBL] [Abstract][Full Text] [Related]
9. Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis. Foo CS; Lupien A; Kienle M; Vocat A; Benjak A; Sommer R; Lamprecht DA; Steyn AJC; Pethe K; Piton J; Altmann KH; Cole ST mBio; 2018 Oct; 9(5):. PubMed ID: 30301850 [TBL] [Abstract][Full Text] [Related]
10. The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd. Lu P; Asseri AH; Kremer M; Maaskant J; Ummels R; Lill H; Bald D Sci Rep; 2018 Feb; 8(1):2625. PubMed ID: 29422632 [TBL] [Abstract][Full Text] [Related]
11. Cryo-Electron Microscopy Structure of the Mathiyazakan V; Wong CF; Harikishore A; Pethe K; Grüber G Antimicrob Agents Chemother; 2023 Jun; 67(6):e0153122. PubMed ID: 37158740 [TBL] [Abstract][Full Text] [Related]
12. Targeting the cytochrome oxidases for drug development in mycobacteria. Lee BS; Sviriaeva E; Pethe K Prog Biophys Mol Biol; 2020 May; 152():45-54. PubMed ID: 32081616 [TBL] [Abstract][Full Text] [Related]
13. An amiloride derivative is active against the F Hards K; Cheung CY; Waller N; Adolph C; Keighley L; Tee ZS; Harold LK; Menorca A; Bujaroski RS; Buckley BJ; Tyndall JDA; McNeil MB; Rhee KY; Opel-Reading HK; Krause K; Preiss L; Langer JD; Meier T; Hasenoehrl EJ; Berney M; Kelso MJ; Cook GM Commun Biol; 2022 Feb; 5(1):166. PubMed ID: 35210534 [TBL] [Abstract][Full Text] [Related]
14. Syntheses and Structure-Activity Relationships of Hopfner SM; Lee BS; Kalia NP; Miller MJ; Pethe K; Moraski GC Appl Sci (Basel); 2021 Oct; 11(19):. PubMed ID: 36698770 [TBL] [Abstract][Full Text] [Related]
15. Cytochrome Saha P; Das S; Indurthi HK; Kumar R; Roy A; Kalia NP; Sharma DK RSC Med Chem; 2024 Mar; 15(3):769-787. PubMed ID: 38516593 [TBL] [Abstract][Full Text] [Related]
16. Response of Chauhan P; van der Meulen SA; Simões Caetano JM; Goojani HG; Botman D; van Spanning R; Lill H; Bald D Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142240 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and Biological Evaluation of Aurachin D Analogues as Inhibitors of Lawer A; Tyler C; Hards K; Keighley LM; Cheung CY; Kierek F; Su S; Matikonda SS; McInnes T; Tyndall JDA; Krause KL; Cook GM; Gamble AB ACS Med Chem Lett; 2022 Oct; 13(10):1663-1669. PubMed ID: 36262396 [TBL] [Abstract][Full Text] [Related]
18. Carbon metabolism modulates the efficacy of drugs targeting the cytochrome bc Kalia NP; Shi Lee B; Ab Rahman NB; Moraski GC; Miller MJ; Pethe K Sci Rep; 2019 Jun; 9(1):8608. PubMed ID: 31197236 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of (Quinazoline 4-yloxy)acetamide and (4-oxoquinazoline-3(4H)-yl)acetamide derivatives as inhibitors of Mycobacterium tuberculosis bd oxidase. Kumar A; Kumari N; Bhattacherjee S; Venugopal U; Parwez S; Siddiqi MI; Krishnan MY; Panda G Eur J Med Chem; 2022 Nov; 242():114639. PubMed ID: 35973312 [TBL] [Abstract][Full Text] [Related]
20. Cytochrome bd in Mycobacterium tuberculosis: A respiratory chain protein involved in the defense against antibacterials. Mascolo L; Bald D Prog Biophys Mol Biol; 2020 May; 152():55-63. PubMed ID: 31738981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]